Literature DB >> 9408094

Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.

K Källén1, M Heiling, A M Andersson, A Brun, S Holtås, E Ryding, I Rosén.   

Abstract

OBJECTIVE: To investigate patients with cystic enhancing lesions on CT and to determine whether thallium-201 (201Tl) SPECT adds to further preoperative information in differential diagnosis between gliomas and abscesses.
METHODS: Twenty one patients with cystic ring enhancing CT findings were studied and uptake indices were compared with CT enhancement volumes, histopathology, and survival times.
RESULTS: Fourteen high grade gliomas, three low grade gliomas, and four abscesses were found. Uptake was higher in the highly malignant glioma group (median thallium index (TI)=2.1), than in the low grade glioma group (median TI=1.4) or among the abscesses (median TI=1.6). Overlapping indices were found between high and low malignant cystic gliomas as well as between either one of the glioma groups and the infectious lesions, and there were no significant differences between groups. There was a level at the value 2, where TI > or = 2 correlated with tumour diagnosis. One low grade tumour had an extremely high index and a very high enhancement volume. Indices correlated significantly with CT enhancement volumes (P=0.005). There was no significant correlation between Tl indices and patient survival times among the high grade gliomas. One patient with a highly malignant tumour but low Tl uptake < 2, had a survival > five years.
CONCLUSIONS: It is concluded that high 201Tl uptake in enhancing cystic lesions is an indicator of highly malignant glioma. However, the differentiation between the high malignant gliomas and abscesses or low malignant gliomas by 201TL SPECT is only partial with an overlap between these groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408094      PMCID: PMC2169806          DOI: 10.1136/jnnp.63.5.569

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Thallium activation of the (Na+--K+)-activated ATPase of rabbit kidney.

Authors:  J S Britten; M Blank
Journal:  Biochim Biophys Acta       Date:  1968-04-24

2.  SPECT imaging of gliomas with Thallium-201 and Technetium-99m-HMPAO.

Authors:  H Sjöholm; D Elmqvist; S Rehncrona; I Rosén; L G Salford
Journal:  Acta Neurol Scand       Date:  1995-01       Impact factor: 3.209

Review 3.  Adjuvant and neoadjuvant treatment for primary brain tumors in adults.

Authors:  S A Grossman; L K Norris
Journal:  Semin Oncol       Date:  1995-12       Impact factor: 4.929

Review 4.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; A J Fischbach; C H Chang; M Rotman; S O Asbell; R E Krisch
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

6.  Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.

Authors:  N Oriuchi; M Tamura; T Shibazaki; C Ohye; N Watanabe; M Tateno; K Tomiyoshi; T Hirano; T Inoue; K Endo
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

7.  Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology.

Authors:  W J Slizofski; L Krishna; C D Katsetos; P Black; C Miyamoto; S J Brown; J Vender; A Chevres; A S Khan; J McEwan
Journal:  Cancer       Date:  1994-12-15       Impact factor: 6.860

8.  Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT.

Authors:  K Källén; M Heiling; A M Andersson; A Brun; S Holtås; E Ryding
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

9.  Variation in appearance of glioma on serial thallium-201 single photon emission computed tomography--case report.

Authors:  H Kimura; Y Takeno; T Fukushima
Journal:  Neurol Med Chir (Tokyo)       Date:  1995-05       Impact factor: 1.742

10.  Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients.

Authors:  A Ruiz; W I Ganz; M J Post; A Camp; H Landy; W Mallin; G N Sfakianakis
Journal:  AJNR Am J Neuroradiol       Date:  1994-11       Impact factor: 3.825

View more
  3 in total

1.  Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.

Authors:  Michail Plotkin; C Blechschmidt; G Auf; F Nyuyki; L Geworski; T Denecke; W Brenner; F Stockhammer
Journal:  Eur Radiol       Date:  2010-06-03       Impact factor: 5.315

2.  201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.

Authors:  K Kallén; I M Burtscher; S Holtås; E Ryding; I Rosén
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

3.  CT-based quantitative SPECT for the radionuclide ²⁰¹Tl: experimental validation and a standardized uptake value for brain tumour patients.

Authors:  Kathy Willowson; Dale Bailey; Geoff Schembri; Clive Baldock
Journal:  Cancer Imaging       Date:  2012       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.